Cargando…
Immunological Monitoring to Rationally Guide AAV Gene Therapy
Recent successes with adeno-associated virus (AAV)-based gene therapies fuel the hope for new treatments for hereditary diseases. Pre-existing as well as therapy-induced immune responses against both AAV and the encoded transgenes have been described and may impact on safety and efficacy of gene the...
Autores principales: | Britten, Cedrik Michael, Walter, Steffen, Janetzki, Sylvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770921/ https://www.ncbi.nlm.nih.gov/pubmed/24062741 http://dx.doi.org/10.3389/fimmu.2013.00273 |
Ejemplares similares
-
Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring
por: Hoos, Axel, et al.
Publicado: (2012) -
Editorial: “AAV Gene Therapy: Immunology and Immunotherapeutics”
por: Martinez-Navio, José M., et al.
Publicado: (2021) -
Immunology of AAV-Mediated Gene Transfer in the Eye
por: Willett, Keirnan, et al.
Publicado: (2013) -
Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions
por: Weber, Thomas
Publicado: (2021) -
Immunogenicity and toxicity of AAV gene therapy
por: Ertl, Hildegund C. J.
Publicado: (2022)